Two novel angiotensin‐converting enzyme (ACE) and dipeptidyl peptidase IV (DPP‐IV) inhibiting peptides from tilapia (Oreochromis mossambicus) skin and their molecular docking mechanism

In the study, papain was used to hydrolyze tilapia (Oreochromis mossambicus) skin to obtain a tilapia skin hydrolysate (TSH) with dual angiotensin‐converting enzyme (ACE) and dipeptidyl peptidase IV (DPP‐IV) inhibitory activities. The resulting TSH was sequentially fractionated by ultrafiltration, size exclusion separation chromatography, and reverse‐phase high‐performance liquid chromatography. Its inhibitory effects on ACE and DPP‐IV were determined by commercial reagent kits. Two peptides purified from TSH were identified as Gly‐Pro‐Leu‐Gly‐Ala‐Leu (GPLGAL) and Lys‐Pro‐Ala‐Gly‐Asn (KPAGN) by the ultra‐performance liquid chromatography–tandem mass spectrometry (UPLC–MS/MS). Inhibitory concentration (IC50) of GPLGAL on ACE and DPP‐IV were 117.20 ± 1.69 and 187.10 ± 2.75 µM, respectively. IC50 of KPAGN on ACE and DPP‐IV were 137.40 ± 2.33 and 259.20 ± 2.85 µM, respectively. The molecular simulation demonstrated that the binding affinities of GPLGAL to ACE and DPP‐IV proteins were −8.5 and −7.4 kcal/mol, respectively, whereas those of KPAGN to ACE and DPP‐IV proteins were −7.9 and −6.7 kcal/mol, respectively. GPLGAL interacted with 21 amino acid residues of the ACE active site, whereas KPAGN engaged with 19 amino acid residues. Additionally, GPLGAL interacted with 10 amino acid residues of the DPP‐IV active site, whereas KPAGN engaged with 13 amino acid residues. The two peptides predominantly occupied the active sites of ACE (His513, Tyr523, and Ala354) and DPP‐IV (Tyr662 and Arg125) through hydrogen bonding. This leads to the deactivation of ACE and DPP‐IV. Practical Application Accelerate tilapia skin development and high‐value utilization; provide foundation for preparing the peptides with dual ACE and DPP‐IV inhibiting activity.